Eccentric contractions do not induce rhabdomyolysis in malignant hyperthermia susceptible mice.
Recent studies suggest a link between exercise-induced rhabdomyolysis and mutations of the ryanodine receptor (RYR1) associated with malignant hyperthermia (MH). We hypothesized that MH-susceptible mice (RYR1Y522S/wt) would exhibit greater anterior crural muscle [tibialis anterior (TA) and extensor digitorum longus (EDL) muscles] damage and strength deficits following the performance of a single or repeated bouts of eccentric contractions compared with wild-type (WT) mice. After a single injury bout, RYR1Y522S/wt mice produced more isometric torque than WT mice immediately and 3 and 7 days postinjury. Moreover, EDL muscle isometric specific force deficits were fully recovered for RYR1Y522S/wt but not WT mice 14 days postinjury. The percentage of fibers in TA muscle exhibiting signs of muscle damage 7 and 14 days postinjury were at least three times less in RYR1Y522S/wt than in WT mice. Uninjured and injured EDL muscle from RYR1Y522S/wt mice also displayed greater S-glutathionylation of RYR1 than that from WT mice. During the weekly injury bouts, torque production by RYR1Y522S/wt mice was fully recovered before the third and fourth injury bouts, whereas torque was still reduced for WT mice. Three days after multiple injury bouts, there were approximately 50% fewer fibers exhibiting signs of muscle damage in RYR1Y522S/wt than in WT TA muscle. These findings indicate that the RYR1Y522S/wt mutation protects skeletal muscle from exercise-induced muscle injury and do not support a direct association between MH susceptibility and contraction-induced rhabdomyolysis when core temperature is maintained at lower physiological temperatures during exercise.
Corona
Benjamin T
BT
Muscle Biology Laboratory, Department of Kinesiology and Health, Georgia State University, Atlanta, GA 30302-3975, USA.
Rouviere
Clement
C
Hamilton
Susan L
SL
Ingalls
Christopher P
CP
D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D005978:Glutathione / Q000378:metabolism; D007537:Isometric Contraction / Q000187:drug effects; D008305:Malignant Hyperthermia / Q000150:complications / Q000378:metabolism / Q000503:physiopathology*; D051379:Mice; D008817:Mice, Mutant Strains; D053580:Muscle Strength / Q000187:drug effects; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D009154:Mutation; D010084:Oxidation-Reduction; D010641:Phenotype; D012206:Rhabdomyolysis / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D019837:Ryanodine Receptor Calcium Release Channel / Q000235:genetics / Q000378:metabolism*; D013997:Time Factors; D019415:Torque
D019837:Ryanodine Receptor Calcium Release Channel; D002110:Caffeine; D005978:Glutathione
FASEB J. 2006 Feb;20(2):329-30
16284304
Cell. 2008 Apr 4;133(1):53-65
18394989
J Clin Anesth. 1997 Feb;9(1):66-8
9051549
Int J Clin Pract. 1999 Sep;53(6):476-7
10622078
J Physiol. 1993 May;464:457-75
8229813
Anesthesiology. 2001 Jan;94(1):95-100
11135728
J Biol Chem. 1995 Oct 27;270(43):25557-63
7592726
Histochem J. 1998 Mar;30(3):121-2
10188921
Exerc Sport Sci Rev. 2001 Apr;29(2):82-7
11337828
J Biol Chem. 2001 Dec 21;276(51):48077-82
11673462
J Biol Chem. 2003 Oct 31;278(44):42927-35
12920114
Am J Physiol Cell Physiol. 2002 Apr;282(4):C684-92
11880257
J Muscle Res Cell Motil. 1998 Apr;19(3):215-24
9583362
J Biol Chem. 2006 Dec 29;281(52):40354-68
17071618
Biophys J. 2000 Jul;79(1):279-86
10866954
J Appl Physiol (1985). 1990 Mar;68(3):1241-51
2111311
J Neurol Sci. 2001 Dec 15;193(1):7-11
11718743
Exerc Sport Sci Rev. 2004 Oct;32(4):174-9
15604937
Prev Med. 2001 Nov;33(5):503-13
11676593
Cell Calcium. 1997 Nov;22(5):373-83
9448944
Ann Hum Genet. 2000 Jul;64(Pt 4):307-20
11415515
Biochimie. 2001 Mar-Apr;83(3-4):301-10
11295490
J Appl Physiol (1985). 1996 Dec;81(6):2555-64
9018506
Br J Anaesth. 2002 Apr;88(4):508-15
12066726
Sports Med. 2007;37(4-5):361-3
17465608
J Physiol. 1999 Mar 1;515 ( Pt 2):609-19
10050026
J Biol Chem. 2004 Oct 15;279(42):43838-46
15299003
J Physiol. 2005 Jan 15;562(Pt 2):367-80
15528244
Acta Physiol Scand. 2004 Jun;181(2):217-24
15180794
Am J Physiol Regul Integr Comp Physiol. 2002 Apr;282(4):R1122-32
11893617
Br J Anaesth. 2000 Jul;85(1):118-28
10928000
Am J Hum Genet. 2006 Nov;79(5):859-68
17033962
Int J Biochem Cell Biol. 2005 Oct;37(10):2134-46
15893952
Anaesth Intensive Care. 1998 Jun;26(3):315-8
9619231
J Appl Physiol (1985). 1996 Jan;80(1):278-84
8847315
J Biol Chem. 1989 Dec 25;264(36):21725-36
2532212
Clin Nephrol. 2003 Oct;60(4):296-7
14579948
J Physiol. 1995 Oct 1;488 ( Pt 1):25-36
8568662
J Appl Physiol (1985). 1986 Jul;61(1):293-9
3733615
Pediatr Emerg Care. 1997 Dec;13(6):382-5
9434995
Am J Sports Med. 2004 Mar;32(2):503-8
14977681
Orphanet J Rare Dis. 2007 Apr 24;2:21
17456235
Scand J Med Sci Sports. 2003 Apr;13(2):88-97
12641640
Brain. 2007 Aug;130(Pt 8):2024-36
17483490
J Physiol. 2004 Nov 1;560(Pt 3):617-26
15331687
J Appl Physiol (1985). 1995 Oct;79(4):1260-70
8567571
J Appl Physiol (1985). 2007 Feb;102(2):755-61
17068209
J Appl Physiol (1985). 1998 Jul;85(1):58-67
9655756
J Physiol. 2003 Mar 15;547(Pt 3):807-23
12562929
J Appl Physiol (1985). 2004 Sep;97(3):1067-76
15121748
Cell Calcium. 2005 Feb;37(2):121-7
15589992
J Appl Physiol (1985). 2004 May;96(5):1619-25
14672973
J Neurol Sci. 1993 Nov;119(2):169-79
8277331